Cargando…

Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinoma

Assessment of ERBB2 (HER2) status in breast carcinomas has become critical in determining response to the humanised monoclonal antibody trastuzumab. The current joint College of American Pathologists and the American Society of Clinical Oncology guidelines for the evaluation of HER2 status in breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruver, Aaron M, Peerwani, Ziad, Tubbs, Raymond R
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Group 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921277/ https://www.ncbi.nlm.nih.gov/pubmed/20203220 http://dx.doi.org/10.1136/jcp.2009.062760

Ejemplares similares

Comparison of Chromogenic In Situ Hybridisation with Fluorescence In Situ Hybridisation and Immunohistochemistry for the Assessment of Her-2/neu Oncogene in Archival Material of Breast Carcinoma
por: Pothos, Alexios, et al.
Publicado: (2008)

Comparison of HER2 status by fluorescence in situ hybridisation and immunohistochemistry in gastric cancer
por: Chen, Ming, et al.
Publicado: (2014)

Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer
por: Arnould, L, et al.
Publicado: (2003)

Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study
por: van de Vijver, Marc, et al.
Publicado: (2007)

Detection of c-erbB-2 mRNAs Using Dig-Labelled Oligonucleotide Probe with in situ Hybridisation in Human Breast Carcinoma: Comparison with Immunohistochemical Results
por: Öztürk, Melek, et al.
Publicado: (1998)

Concomitant Detection of HER2 Protein and Gene Alterations by Immunohistochemistry (IHC) and Silver Enhanced In Situ Hybridization (SISH) Identifies HER2 Positive Breast Cancer with and without Gene Amplification
por: Varga, Zsuzsanna, et al.
Publicado: (2014)

The perception of brightness and darkness
por: Hurvich, Leo M. (Leo Maurice), 1910-2009
Publicado: (1966)

ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells
por: Choi, Byung-Kwon, et al.
Publicado: (2012)

Fluorescence in situ hybridisation in Carnoy’s fixed tonsil tissue
por: Clark, S. T., et al.
Publicado: (2022)

Improvement of RNA In Situ Hybridisation for Grapevine Fruits and Ovules
por: Yao, Jin, et al.
Publicado: (2023)

When Do Narcissists Burn Out? The Bright and Dark Side of Narcissism in Surgeons
por: Rana, Madiha, et al.
Publicado: (2022)

The Mysterious Ways of ErbB2/HER2 Trafficking
por: Bertelsen, Vibeke, et al.
Publicado: (2014)

Bright galaxies, dark matters
por: Rubin, Vera
Publicado: (1996)

Brightness and Darkness as Perceptual Dimensions
por: Vladusich, Tony, et al.
Publicado: (2007)

The bright and dark sides of egoism
por: Weiß, Martin, et al.
Publicado: (2022)

In situ analysis of cross-hybridisation on microarrays and the inference of expression correlation
por: Casneuf, Tineke, et al.
Publicado: (2007)

Detection of feline haemoplasma species in experimental infections by in-situ hybridisation
por: Peters, Iain R., et al.
Publicado: (2011)

Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3
por: Ross, Jeffrey S., et al.
Publicado: (2018)

Getting DNA and RNA out of the dark with 2CNqA: a bright adenine analogue and interbase FRET donor
por: Wypijewska del Nogal, Anna, et al.
Publicado: (2020)

Prognostic value of ErbB2/HER2 in human meningiomas
por: Arnli, Magnus B., et al.
Publicado: (2018)

ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
por: Joshi, Sunil K., et al.
Publicado: (2020)

HER2 therapy. HER2 (ERBB2): functional diversity from structurally conserved building blocks
por: Landgraf, Ralf
Publicado: (2007)

HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma
por: Portier, Bryce P, et al.
Publicado: (2013)

An optimised whole mount in situ hybridisation protocol for the mollusc Lymnaea stagnalis
por: Hohagen, Jennifer, et al.
Publicado: (2015)

Preparation of fluorescent in situ hybridisation probes without the need for optimisation of fragmentation
por: McCoy, Patrick J., et al.
Publicado: (2018)

Detection of specific uncultured bacteriophages by fluorescence in situ hybridisation in pig microbiome
por: Ostenfeld, Line Jensen, et al.
Publicado: (2023)

Fluorescence in situ hybridisation for interphase chromosomal aberration-based biological dosimetry
por: Meher, Prabodha Kumar, et al.
Publicado: (2023)

Radiotherapy: Brightness and darkness in the era of immunotherapy
por: Zhai, Danyi, et al.
Publicado: (2022)

Editorial: The dark or bright side of entrepreneurship
por: Wu, Yenchun Jim, et al.
Publicado: (2022)

Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies
por: Randall, Kevin, et al.
Publicado: (2016)

Asymmetric Brightness Effects With Dark Versus Light Glare-Like Stimuli
por: Kobayashi, Yuki, et al.
Publicado: (2021)

Burning bright or burning out?
por: Natarajan, Sundaram
Publicado: (2015)

Exploration of HER2 (ERBB2) immunohistochemistry in non-small cell lung cancer: correlation with ERBB2 mutational status: experimental research
por: Cardillo, Anthony B., et al.
Publicado: (2023)

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis
por: Elbauomy Elsheikh, Somaia, et al.
Publicado: (2007)

Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation.
por: Fabien, N., et al.
Publicado: (1992)

Fluorescence in-situ hybridisation on biopsies from clam ileocystoplasties and on a clam cancer
por: Ivil, K D, et al.
Publicado: (2006)

REG gene expression in inflamed and healthy colon mucosa explored by in situ hybridisation
por: van Beelen Granlund, Atle, et al.
Publicado: (2013)

An assessment of chromosomal alterations detected by fluorescence in situ hybridisation in pancreatobiliary tract malignancy
por: Pu, Xiaohong, et al.
Publicado: (2020)

Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements
por: Yu, Yongbo, et al.
Publicado: (2023)

The tree of knowledge: the bright and the dark sides of science
por: Ronchi, Claudio
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5g0lsu74edd0o0e0pbfdac8c91